. 2022 Aug 17;7(8):190. doi: 10.3390/tropicalmed7080190

Table A2.

Infection rate: $β$ .

Parameters	Description	Value (95% CI)	Source
$β_{1}^{I}$	infection rate of wild strain carriers in stage 1	0.0428 (0.0160, 0.6590)	[15,37]
$β_{2}^{I}$	infection rate of wild strain carriers in stage 2	0.0500 (0.0200, 0.0700)	[37]
$β_{3}^{I}$	infection rate of wild strain carriers in stage 3	0.1000 (0.0500, 0.1400)	[37]
$β_{1}^{T}$	infection rate of wild strain carriers after HAART in stage 1	0.0282 (0.0106, 0.4349)	[14]
$β_{2}^{T}$	infection rate of wild strain carriers after HAART in stage 2	0.0330 (0.0132, 0.0462)	[14]
$β_{3}^{T}$	infection rate of wild strain carriers after HAART in stage 3	0.0120 (0.0060, 0.0168)	[14,38]
$β_{1}^{R}$	infection rate of drug-resistant carriers in stage 1	$ϵ β_{1}^{I}$
$β_{2}^{R}$	infection rate of drug-resistant carriers in stage 2	$ϵ β_{2}^{I}$
$β_{3}^{R}$	infection rate of drug-resistant carriers in stage 3	$ϵ β_{3}^{I}$
$ϵ$	transmissibility ratio of drug-resistant to untreated wild strain carriers	fit